Xiao X. Wei

Sigmund Freud Str. 25
Bonn, NW 53127, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 70 publications

Long-term follow-up from the OMNIVORE trial: response-adaptive nivolumab and ipilimumab in advanced renal cell carcinoma.

Long-term follow-up from the OMNIVORE trial: response-adaptive nivolumab and ipilimumab in advanced renal cell carcinoma.

Journal: Journal for immunotherapy of cancer

Published: June 22, 2026

Longitudinal Phenotyping of Circulating Tumor Cells using a Scalable Deep Learning Framework.

Longitudinal Phenotyping of Circulating Tumor Cells using a Scalable Deep Learning Framework.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: February 23, 2026

National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations.

National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 23, 2025

LASER: A Phase 2 Trial of 177Lu-PSMA-617 as Systemic Therapy for RCC.

LASER: A Phase 2 Trial of 177Lu-PSMA-617 as Systemic Therapy for RCC.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: September 13, 2025

Phase 1 Trial of P-PSMA-101 CAR-T Cells in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC).

Phase 1 Trial of P-PSMA-101 CAR-T Cells in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC).

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 11, 2025

Phase I Trial of P-PSMA-101 CAR T Cells in Patients with Metastatic Castration-Resistant Prostate Cancer.

Phase I Trial of P-PSMA-101 CAR T Cells in Patients with Metastatic Castration-Resistant Prostate Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 11, 2025

Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8+ and PD-1+ Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk Factors.

Immunoprofiling at an Institutional Scale Reveals That High Numbers of Intratumoral CD8+ and PD-1+ Cells Predict Superior Patient Survival Across Major Cancer Types Independent of Major Risk Factors.

Journal: JCO precision oncology

Published: September 04, 2025

Examining Patient Characteristics in Bladder Cancer Clinical Trials Involving Immunotherapy.

Examining Patient Characteristics in Bladder Cancer Clinical Trials Involving Immunotherapy.

Journal: Journal of clinical medicine

Published: December 17, 2024

Outcome of Subsequent Therapies After 177Lu-Vipivotide Tetraxetan for Metastatic Castrate-Resistant Prostate Cancer: A Tertiary Cancer Center Experience.

Outcome of Subsequent Therapies After 177Lu-Vipivotide Tetraxetan for Metastatic Castrate-Resistant Prostate Cancer: A Tertiary Cancer Center Experience.

Journal: The Prostate

Published: October 22, 2024

High-purity CTC RNA sequencing identifies prostate cancer lineage phenotypes prognostic for clinical outcomes.

High-purity CTC RNA sequencing identifies prostate cancer lineage phenotypes prognostic for clinical outcomes.

Journal: Cancer discovery

Published: October 17, 2024

Quantitative 68Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following 177Lu-PSMA-617 (VISION Trial).

Quantitative 68Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following 177Lu-PSMA-617 (VISION Trial).

Journal: Radiology

Published: August 20, 2024

Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate Cancer.

Combined Fixed-duration Systemic Treatment and Metastasis-directed Radiotherapy for Oligometastatic Hormone-sensitive Prostate Cancer.

Journal: European urology oncology

Published: August 19, 2024

Showing 1-12 of 70

Last Updated: 09/26/2026